EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSACIG00000013424
Gene Symbol: RARG
1 Cross references
383 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSACIG00000010476
Gene Symbol: ROCK2A
1 Cross references
216 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSACIG00000010153
Gene Symbol: ROCK2B
1 Cross references
214 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSACIG00000001176
Gene Symbol: RPL11
1 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSACIG00000012843
Gene Symbol: RPL12
1 Cross references
489 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSACIG00000004871
Gene Symbol: RPL13A
1 Cross references
370 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSACIG00000015360
Gene Symbol: RPL14
1 Cross references
306 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSACIG00000002106
Gene Symbol: RPL14
1 Cross references
304 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSACIG00000008813
Gene Symbol: RPL15
1 Cross references
376 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSACIG00000006925
Gene Symbol: RPL18
1 Cross references
379 Possible Orthologues:

Ribosomal Protein L21

Ensembl ID : ENSACIG00000021885
Gene Symbol: RPL21
1 Cross references
783 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSACIG00000012777
Gene Symbol: RPL22
1 Cross references
364 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).